{
  "profile_url": "https://www.moffitt.org/research-science/researchers/richard-kim/",
  "last_updated": "2025-11-21T22:50:26.559734",
  "researcher_id": "7658",
  "degrees": [
    "MD"
  ],
  "title": "",
  "primary_program": "gastrointestinal oncology",
  "research_program": "molecular medicine",
  "overview": "Dr. Kim\u2019s clinical and research interests focus on gastrointestinal tumors, in particular hepatobiliary and colon cancer. He is a principal investigator in multiple investigator-initiated and pharmaceutical phase I and II trials using novel targeted agents.",
  "research_interests": [
    "Dr. Richard Kim specializes in gastrointestinal oncology. As a clinical investigator, Dr. Kim\u2019s main interest is conducting novel clinical trials. Currently he is a principal investigator in multiple investigator-initiated and pharmaceutical phase I and phase II trials using novel targeted agents in gastrointestinal tumors, especially focusing on hepatobiliary and colon cancer.\n  *"
  ],
  "associations": [
    "Gastrointestinal Oncology",
    "Molecular Medicine Program",
    "Experimental Therapeutics Program"
  ],
  "education": [
    {
      "type": "Graduate",
      "institution": "Yale University Comprehensive Cancer Center, Postdoctoral Fellow"
    },
    {
      "type": "Medical School",
      "institution": "University of Miami School of Medicine",
      "degree": "MD"
    },
    {
      "type": "Internship",
      "institution": "New York University Downtown Hospital",
      "position": "Intern",
      "specialty": "Internal Medicine"
    },
    {
      "type": "Residency",
      "institution": "University of Illinois",
      "position": "Intern",
      "specialty": "al Medicine"
    }
  ],
  "publications": [
    {
      "title": "Linkage disequilibrium score regression identifies genetic correlations between hepatocellular carcinoma and clinically relevant traits",
      "pubmed_id": "41013983",
      "year": "2025",
      "publication_date": "2025 Sep",
      "authors": "Han Y, Shaw VR, Byun J, Thrift AP, Zhu C, Li D, Hatia RI, Kelley RK, Cleary SP, Lok AS, Bracci PM, Permuth JB, Bucur R, Knox J, Yuan JM, Singal AG, Jalal PK, Ghobrial RM, Kono Y, Shah DP, Nguyen MH, Parikh ND, Kim R, Wu HC, El-Serag H, Chang P, Chun YS, Gu J, Huff C, Rashid A, Hwang LY, Klein AP, Khaderi SA, Kaseb AO, McGlynn KA, Roberts LR, Hassan MM, Amos CI",
      "journal": "Int J Cancer"
    },
    {
      "title": "Intrahepatic cholangiocarcinoma: role of imaging as a critical component for multi-disciplinary treatment approach",
      "pubmed_id": "40095023",
      "year": "2025",
      "publication_date": "2025 Sep",
      "authors": "Childers BG, Denbo JW, Kim RD, Hoffe SE, Glushko T, Qayyum A, Anaya DA",
      "journal": "Abdom Radiol (NY)"
    },
    {
      "title": "Role of neoadjuvant therapies in locally advanced colon cancer",
      "pubmed_id": "40736234",
      "pmc_id": "PMC12407165",
      "year": "2025",
      "publication_date": "2025 Sep",
      "authors": "de Castria TB, Lenz G, Valagni G, Kim RD",
      "journal": "Chin Med J (Engl)"
    },
    {
      "title": "Real-World Study of Patients with Metastatic Colorectal Cancer and Long-Term Response to Regorafenib in the USA",
      "pubmed_id": "41097724",
      "pmc_id": "PMC12523651",
      "year": "2025",
      "publication_date": "2025 Sep",
      "authors": "Kim RD, Pan X, Zhang Y, Lunacsek O, Pisa F, Ostojic H, Peeters M",
      "journal": "Cancers (Basel)"
    },
    {
      "title": "Acute Change in Perceived Cognitive Performance Across Different Age Groups Following First Chemotherapy Infusion in Female Patients With Breast Cancer",
      "pubmed_id": "41058041",
      "year": "2025",
      "publication_date": "2025 Oct",
      "authors": "Yang HY, Li X, Hoogland AI, Welniak TL, Rodriguez Y, Carpenter KM, Fischer SM, Kinney AY, Li D, Nguyen O, Rotroff DM, Mariam A, Berry DL, Extermann M, Kim R, Lee KT, Jim HSL",
      "journal": "Psychooncology"
    },
    {
      "title": "Association of Pathologic Response and Adjuvant Chemotherapy with Survival in Resected Pancreatic Ductal Adenocarcinoma Following Neoadjuvant Therapy",
      "pubmed_id": "40507279",
      "pmc_id": "PMC12153592",
      "year": "2025",
      "publication_date": "2025 May",
      "authors": "Yu J, Laborde JM, Park R, Shahzad M, Kim Y, Cheon J, Imanirad I, Kim RD, Biachi de Castria T, Nardella NL, Malafa M, Denbo JW, Fleming JB, Hoffe SE, Frakes JM, Sinnamon AJ, Pimiento JM, Hodul PJ, Kim DW",
      "journal": "Cancers (Basel)"
    },
    {
      "title": "Real-World Experiences Using Atezolizumab + Bevacizumab for the Treatment of Unresectable Hepatocellular Carcinoma: A Multicenter Study",
      "pubmed_id": "40507295",
      "pmc_id": "PMC12153728",
      "year": "2025",
      "publication_date": "2025 May",
      "authors": "Abdelrahim M, Esmail A, Kim RD, Arora SP, Arshad J, Kournoutas IA, O'Donnell CD, Totev TI, Tan A, Mu F, Seshasayee SM, Hernandez S, Tran NH",
      "journal": "Cancers (Basel)"
    },
    {
      "title": "Safety of current treatments for advanced cholangiocarcinoma",
      "pubmed_id": "39718803",
      "year": "2025",
      "publication_date": "2025 Mar",
      "authors": "de Castria TB, Kim RD",
      "journal": "Expert Opin Drug Saf"
    },
    {
      "title": "Practice Patterns and Survival Outcomes of Immunotherapy for Metastatic Colorectal Cancer",
      "pubmed_id": "40111368",
      "pmc_id": "PMC11926646",
      "year": "2025",
      "publication_date": "2025 Mar",
      "authors": "Bari S, Matejcic M, Kim RD, Xie H, Sahin IH, Powers BD, Teer JK, Chan TA, Felder SI, Schmit SL",
      "journal": "JAMA Netw Open"
    },
    {
      "title": "Molecular signatures of intrahepatic cholangiocarcinoma: role in targeted therapy selection",
      "pubmed_id": "40222184",
      "year": "2025",
      "publication_date": "2025 Jun",
      "authors": "Glushko T, Costello J, Chima R, McGettigan M, Kim R, Jeong D, Qayyum A",
      "journal": "Eur J Radiol"
    }
  ],
  "grants": [],
  "participating_trials": [
    {
      "trial_url": "https://www.moffitt.org/clinical-trials-and-studies/clinical-trial-21923/",
      "trial_id": "21923",
      "title": "A Phase 1b/2 Multicenter, Open-label Study to Evaluate the Safety and Efficacy of TTI-101 as Monotherapy and in Combination in Participants with Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma",
      "condition": "Gastrointestinal Tumor",
      "intervention": "Atezolizumab (Tecentriq); Avastin (Bevacizumab); Bevacizumab (); Pembrolizumab (Keytruda); TTI-101 ()",
      "status": "Open"
    },
    {
      "trial_url": "https://www.moffitt.org/clinical-trials-and-studies/clinical-trial-22483/",
      "trial_id": "22483",
      "title": "Phase 1b/2a Study of GNS561 in Combination with Trametinib in Advanced KRAS Mutated Cholangiocarcinoma",
      "condition": "Gastrointestinal Tumor",
      "intervention": "Ezurpimtrostat (GNS561) (); GSK1120212 (Trametinib); Trametinib ()",
      "status": "Open"
    },
    {
      "trial_url": "https://www.moffitt.org/clinical-trials-and-studies/clinical-trial-23065/",
      "trial_id": "23065",
      "title": "A Phase 2, Open-label, Multicenter Study Investigating RP2 Oncolytic Immunotherapy in Combination with Second-line Therapy in Patients with Locally Advanced Unresectable, Recurrent and/or Metastatic Hepatocellular Carcinoma",
      "condition": "Gastrointestinal Tumor",
      "intervention": "AMP-514 (Durvalumab); Atezolizumab (Tecentriq); Avastin (Bevacizumab); Bevacizumab (); Durvalumab (); MEDI4736 (Durvalumab); RP2 ()",
      "status": "Open"
    },
    {
      "trial_url": "https://www.moffitt.org/clinical-trials-and-studies/clinical-trial-23132/",
      "trial_id": "23132",
      "title": "A Phase 1 Study of SGN-EGFRd2 in Advanced Solid Tumors",
      "condition": "Gastrointestinal Tumor",
      "intervention": "SGN-EGFRd2 (PF-08046052)",
      "status": "Open"
    },
    {
      "trial_url": "https://www.moffitt.org/clinical-trials-and-studies/clinical-trial-23480/",
      "trial_id": "23480",
      "title": "A Phase 1/2 Study of a Selective FGFR2/3 Inhibitor, CGT4859, in Patients With Cholangiocarcinoma and Other Advanced Solid Tumors Harboring FGFR2 and/or FGFR3 Genetic Alterations",
      "condition": "Multiple",
      "intervention": "CGT4859 ()",
      "status": "Open"
    },
    {
      "trial_url": "https://www.moffitt.org/clinical-trials-and-studies/clinical-trial-23536/",
      "trial_id": "23536",
      "title": "A Phase I/II Open-Label Study to Evaluate the Safety, Cellular Kinetics and Efficacy of AZD5851, a Chimeric Antigen Receptor T-Cell (CAR-T) Therapy Directed Against GPC3 in Adult Participants With Advanced/Recurrent Hepatocellular Carcinoma: ATHENA",
      "condition": "Gastrointestinal Tumor",
      "intervention": "AZD5851 (); cyclophosphamide (); cytoxan (cyclophosphamide); fludarabine (Fludarabine phosphate)",
      "status": "OPEN (SUSPENDED)"
    },
    {
      "trial_url": "https://www.moffitt.org/clinical-trials-and-studies/clinical-trial-23589/",
      "trial_id": "23589",
      "title": "A Phase 1, Open-Label Study of ABSK-011 to Assess Safety, Tolerability, and Pharmacokinetics in Patients with Advanced Solid Tumors",
      "condition": "Gastrointestinal Tumor",
      "intervention": "ABSK-011 ()",
      "status": "Open"
    },
    {
      "trial_url": "https://www.moffitt.org/clinical-trials-and-studies/clinical-trial-23659/",
      "trial_id": "23659",
      "title": "A Phase 1/2 Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of ARV-806 in Participants With KRAS G12D Mutated Advanced Solid Tumors",
      "condition": "Multiple",
      "intervention": "ARV-806 ()",
      "status": "Open"
    }
  ],
  "lab_page_url": "",
  "google_scholar_url": "",
  "photo_url": "https://www.moffitt.org/globalassets/images/researchers_bio/KimRichard_7658.jpg",
  "contact": {
    "contact_url": "https://eforms.moffitt.org/ContactResearchersForm?PERID=7658"
  },
  "content_hash": "7aca1dd8455737bfde8ce1c9eb49035d4f4424b6b171d4435799394c5e1c7ea5",
  "researcher_name": "richard kim",
  "department": ""
}